Product Information
TUSSIN DM 400-20 MG/20 ML LIQ is a generic product labeled by Cardinal Health, priced at $0.0235 per ML under NDC 70000062801. Its NADAC has been published 80 times since Mar 26, 2025.
Strength
20; 400 mg/20mL; mg/20mL
Manufacturer
Cardinal HealthNDC
70000062801
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/16/2023
Pharmacological Classes
Price Statistics
The NADAC for TUSSIN DM 400-20 MG/20 ML LIQ has been published 80 times since Mar 26, 2025, and over the history we have for it it has risen 27.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0235 per ML |
|---|---|
| All-time high | $0.0237 (Sep 16, 2026) |
| All-time low | $0.0185 (Mar 26, 2025) |
| 52-week high | $0.0237 |
| 52-week low | $0.0210 |
| Median price | $0.0216 |
| Average price | $0.0212 |
| Largest weekly change | +4.6% (Aug 20, 2025) |
| Weeks tracked | 80 |
| Tracking since | Mar 26, 2025 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Dextromethorphan HBr, Guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TUSSIN DM 400-20 MG/20 ML LIQ?
The current National Average Drug Acquisition Cost (NADAC) for TUSSIN DM 400-20 MG/20 ML LIQ, manufactured by Cardinal Health, is $0.0235 per ML (NDC 70000062801), effective Sep 30, 2026.
How has the price of TUSSIN DM 400-20 MG/20 ML LIQ changed over time?
Over the history we have for it, the NADAC for TUSSIN DM 400-20 MG/20 ML LIQ has risen 27.0%. It has been tracked across 80 weekly CMS publications since Mar 26, 2025.
What are the highest and lowest recorded NADAC prices for TUSSIN DM 400-20 MG/20 ML LIQ?
Since Mar 26, 2025, the NADAC for TUSSIN DM 400-20 MG/20 ML LIQ has ranged from a low of $0.0185 (Mar 26, 2025) to a high of $0.0237 (Sep 16, 2026), with a median of $0.0216 per ML.
Are there cheaper alternatives to TUSSIN DM 400-20 MG/20 ML LIQ?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TUSSIN DM 400-20 MG/20 ML LIQ, is $0.0178 per ML — about 24% below TUSSIN DM 400-20 MG/20 ML LIQ.
Who manufactures TUSSIN DM 400-20 MG/20 ML LIQ?
TUSSIN DM 400-20 MG/20 ML LIQ (NDC 70000062801) is labeled by Cardinal Health, and CMS classifies it as a generic product.